Abstract
Many pharmaceuticals and related metabolites are not efficiently removed in sewage treatment plants and enter into surface water. There, they might be subject of drinking water abstraction and treatment by ozonation. In this study, a systematic approach for producing and effect-based testing of transformation products (TPs) during the drinking water ozonation process is proposed. For this, two pharmaceutical parent substances, three metabolites and one environmental degradation product were investigated with respect to their biodegradability and fate during drinking water ozonation. The Ames test (TA98, TA100) was used for the identification of mutagenic activity present in the solutions after testing inherent biodegradability and/or after ozonation of the samples. Suspicious results were complemented with the umu test. Due to the low substrate concentration required for ozonation, all ozonated samples were concentrated via solid phase extraction (SPE) before performing the Ames test. With the exception of piracetam, all substances were only incompletely biodegradable, suggesting the formation of stable TPs. Metformin, piracetam and guanylurea could not be removed completely by the ozonation process. We received some evidence that technical TPs are formed by ozonation of metformin and piracetam, whereas all tested metabolites were not detectable by analytical means after ozonation. In the case of guanylurea, one ozonation TP was identified by LC/MS. None of the experiments showed an increase of mutagenic effects in the Ames test. However, the SPE concentration procedure might lead to false-positive results due to the generation of mutagenic artefacts or might lead to false-negative results by missing adequate recovery efficiency. Thus, these investigations should always be accompanied by process blank controls that are carried out along the whole ozonation and SPE procedure. The study presented here is a first attempt to investigate the significance of transformation products by a systematic approach. However, the adequacy and sensitivity of the methodology need to be further investigated. The approach of combining biodegradation and ozonation with effect-based assays is a promising tool for the early detection of potential hazards from TPs as drinking water contaminants. It can support the strategy for the evaluation of substances and metabolites in drinking water. A multitude of possible factors which influence the results have to be carefully considered, among them the selectivity and sensibility of the mutagenicity test applied, the extraction method for concentrating the relevant compounds and the biocompatibility of the solvent. Therefore, the results have to be carefully interpreted, and possible false-negative and false-positive results should be considered.
Similar content being viewed by others
References
Abegglen C, Escher B, Hollender J, Koepke S, Ort C, Pete A, Siegrist H, von Gunten U, Zimmermann S, Koch M, Niederhauser P, Schärer M, Braun C, Gälli R, Junghans M, Brocker S, Moser R, Rensch D (2009) Ozonation of treated wastewater. Final report of the pilot test Regensdorf. Eawag study on behalf of the Federal Office for the Environment, Switzerland (FOEN) and the Office for Waste, Water, Energy, and Air of the Kanton Zürich, Dübendorf, 16. June 2009 (in German). At: http://www.bafu.admin.ch/gewaesserschutz/03716/03720/04348/index.html
Amy G, Bull R, Craun GF, Pegram RA, Siddiqui M (2000) Disinfectants and disinfectant by-products. United Nations Environment Programme, International Labour Organisation, World Health Organization, International Programme on Chemical Safety. Environmental Health Criteria 216, 1–499. whqlibdoc.who.int/ehc/WHO_EHC_216.pdf
Benner J, Ternes TA (2009a) Ozonation of metoprolol: elucidation of oxidation pathways and major oxidation products. Environ. Sci. Technol. 43 (14), 5472–5480
Benner J, Ternes T (2009b) Ozonation of propranolol: formation of oxidation products. Environ. Sci. Technol. 43 (13), 5086–5093
Broséus R, Vincent S, Aboulfadl K, Daneshvar A, Sauvé S,Barbeau B, Prévost M (2009). Ozone oxidation of pharmaceuticals, endocrine disruptors and pesticides during drinking water treatment. Water Research 43(18), 4707–4717
Dantas RF, Canterino M, Marotta R, Sans C, Esplugas S, Andreozzi R (2007) Bezafibrate removal by means of ozonation: Primary intermediates, kinetics, and toxicity assessment. Water Research 41 (12), 2525–2532
Dieter HH (2011) Drinking water toxicology and its regulatory framework. In: Wilderer P (ed) Treatise on water science, vol 3. Oxford Academic Press, Oxford, pp 377–416
DWA (2008) Anthropogenic micropollutants in the water cycle—pharmaceuticals. DWA-working group KA-8.1, German Association for Water, Wastewater and Waste (DWA), Hennef, Mai 2008 (in German)
Escobar-Garcia D, Camacho-Carranza R, Pérez I, Dorado V, Arriaga-Alba M, Espinosa-Aguirre JJ (2001) S9 induction by the combined treatment with cyclohexanol and albendazole. Mutagenesis 16(6), 523–528
European Commission (2003) Guidance document on the assessment of the relevance of metabolites in groundwater of substances regulated under Council Directive 91/414/EEC. Sanco/221/2000–rev.10—final 25 February 2003 http://ec.europa.eu/food/plant/protection/evaluation/guidance/wrkdoc21_en.pdf
Expert Commission Program Reine Ruhr (2009) Strategy paper: handling of chemical substances not assessed so far in surface water, eraw water, and drinking water. Düsseldorf, December 2009 http://www.agw-nrw.de/fileadmin/pdf/Dokumente_extern/bewertungsstrategie_nicht_bewertbarer_stoffe_091203.pdf
Feldmann DF, Zuehlke S, Heberer T (2008) Occurrence, fate and assessment of polar metamizole (dipyrone) residues in hospital and municipal wastewater. Chemosphere 71(9), 1754–1764
Gartiser S, Urich E, Alexy R, Kümmerer K (2007) Ultimate biodegradation and elimination of antibiotics in inherent tests. Chemosphere 67(3), 604–613
German Federal Environment Agency (2003) Evaluation from the point of view of health of the presence in drinking water of substances that are not (yet) possible or only partially possible to evaluate. Recommendation of the Federal Environment Agency after consultation with the Drinking Water Commission at the Federal Environment Agency. At: http://www.umweltdaten.de/wasser-e/empfnichtbewertbstoffe-english.pdf
Hollender J, Zimmermann SG, Koepke S, Krauss M, McArdell CS, Ort C, Singer H, von Gunten U, Siegrist H. (2009) Elimination of organic micropollutants in a municipal wastewater treatment plant upgraded with a full-scale post-ozonation followed by sand filtration. Environmental Science & Technology 43(20), 7862–7869
Huber MM, Canonica S, Park GY, von Gunten U (2003) Oxidation of pharmaceuticals during ozonation and advanced oxidation processes. Environ. Sci. Technol. 37(5), 1016–1024
ISO 13829 (2000) Determination of the genotoxicity of water and waste water using the umu-test
ISO 16240 (2005) Determination of the genotoxicity of water and waste water—Salmonella/microsome test (Ames test)
ISO 9888 (1999) Evaluation of ultimate aerobic biodegradability of organic compounds in aqueous medium. Static test (Zahn-Wellens method)
Joss A, Zabczynski S, Göbel A, Hoffmann B, Löffler D, McArdella CS, Ternes, TA, Thomsen A, Siegrist H (2006) Biological degradation of pharmaceuticals in municipal wastewater treatment: Proposing a classification scheme. Water Research 40(8), 1686–1696
Kasprzyk-Hordern B, Dinsdale RM, Guwy AJ (2009) The removal of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs during wastewater treatment and its impact on the quality of receiving waters. Water Research 43(2), 363–380
Kern S, Baumgartner R, Helbling DE, Hollender J, Singer H, Loos MJ, Schwarzenbach RP, Fenner K (2010) A tiered procedure for assessing the formation of biotransformation products of pharmaceuticals and biocides during activated sludge treatment. J. Environ. Monit. 12(11), 2100–2111
Kim BS, Margolin BH (1999) Statistical methods for the Ames Salmonella assay: A Review. Mutation Research 436 (1), 113–122
Kolpin DW, Furlong ET, Meyer MT, Thurman EM, Zaugg SD, Barber LB, Buxton HT (2002) Pharmaceuticals, hormones, and other organic wastewater contaminants in US streams, 1999–2000: A national reconnaissance. Environ. Sci. Technol. 36, 1202–1211
Kümmerer K, Schuster A, Längin A, Happel O, Thoma A, Schneider K, Hassauer M, Gartiser S, Hafner C (2009) Identification and assessment of selected pharmaceuticals and their metabolites (degradation and transformation products) in the water cycle. Final Report FKZ 206 61 202 for the German Federal Environment Agency. Freiburg (in German) http://www.umweltdaten.de/publikationen/fpdf-l/4149.pdf
Lee C, Schmidt C, Yoon J, von Gunten U (2007) Oxidation of N-nitrosodimethylamine (NDMA) precursors with ozone and chlorine dioxide: kinetics and effect on NDMA formation potential. Environ. Sci. Technol. 41(6), 2056–2063
Li A, Chen Z, Yang L (2010) Formation, detection and removal of NDMA in water treatment process. Adv Mater Res 113–114:1402–1406
Maron D, Ames BN (1983) Revised methods for the Salmonella mutagenicity test. Mutation Research 113 (3–4), 173–215
Massmann G, Dünnbier U, Heberer T, Taute T (2008) Behaviour and redox sensitivity of pharmaceutical residues during bank filtration - Investigation of residues of phenazone-type analgesics. Chemosphere 71(8), 1476–1485
Matsuda H, Ose Y, Nagase H, Sato T, Kito H, Sumida K (1991) Mutagenicity of the components of substance ozonated humic substance. Sci. Total Environ. 103(2–3), 129–140
Matsushita T, Matsui Y, Inoue T, Taniwaki S, Inoue T (2002) Changes in mutagenicity during biodegradation of fenitrothion. Chemosphere 47(1), 9–14
McDowell DC, Huber MM, Wagner M, von Gunten U, Ternes TA (2005) Ozonation of carbamazepine in drinking water: identification and kinetic study of major oxidation products. Environ. Sci. Technol. 39(20), 8014–8022
Mišík M, Knasmueller S., Ferk F, Cichna-Markl M., Grummt T, Schaar H, Kreuzinger N (2011) Impact of ozonation on the genotoxic activity of tertiary treated municipal wastewater. Water Research 45 (12), 3681–3691
Monarca S, Zani C, Richardson SD, Thruston AD Morettia M, Feretti D, Villarini M (2004) A new approach to evaluating the toxicity and genotoxicity of disinfected drinking water. Water Research 38(17), 3809–3819
OECD 302 B (1992) Zahn-Wellens/EMPA test. OECD Guideline for testing of chemicals. 17 July 1992
OECD 471 (1997) Bacterial reverse mutation test. OECD Guideline for testing of chemicals. 21 July1997
PRIMaT (2012) Preventive risk management for drinking water supply. Research project of the German Ministry of Education and Research within the programme “Risk Management of Emerging Contaminants and Pathogens in the Water Cycle (RiSKWa)". At: http://www.primat.tv
Ringhand HP, Meier JR, Kopfler FC, Schenck KM, Kaylor WH, Mitchell DE (1987) Importance of Sample pH on Recovery of Mutagenicity from Drinking Water by XAD Resins. Environ. Sci. Technol. 21(4), 382–387
Rosal R, Rodríguez A, Perdigón-Melón JA, Mezcua M, Hernando MD, Letón P, García-Calvo E, Agüera A, Fernández-Alba AR (2008) Removal of pharmaceuticals and kinetics of mineralization by O(3)/H(2)O(2) in a biotreated municipal wastewater. Water Research 42(14), 3719–3728
Sánchez-Polo M, Rivera-Utrilla J, Prados-Joya G, Ferro-García MA, Bautista-Toledo I (2008) Removal of pharmaceutical compounds, nitroimidazoles, from waters by using the ozone/carbon system. Water Res. 42(15):4163–4171
Schmidt CK, Brauch HJ (2008) N,N-dimethylsufamide as Precursor for N-nitrosodimethyl-amine (NDMA) Formation upon Ozonation and its Fate During Drinking Water Treatment. Environ. Sci. Technol. 42(17), 6340–6346
Sharma VK (2008) Oxidative transformations of environmental pharmaceuticals by Cl2, ClO2, O3, and Fe(VI): Kinetics assessment (Review). Chemosphere 73 (9), 1379–1386
Snyder SA, Wert EC, Rexing DJ, Zegers RE, Drury DD (2006) Ozone Oxidation of Endocrine Disruptors and Pharmaceuticals in Surface Water and Wastewater. Ozone: Science & Engineering 28, 445–460
Stalter D, Magdeburg A, Oehlmann J (2010). Comparative toxicity assessment of ozone and activated carbon treated sewage effluents using an in vivo test battery. Water Research 44(8), 2610–2620
Sujbert L, Rácz G, Szende B, Schröder HC, Müller WEG, Török G (2006) Genotoxic potential of by-products in drinking water in relation to water disinfection: Survey of pre-ozonated and post-chlorinated drinking water by Ames-test. Toxicology 219(1–3), 106–112
Ternes T, Stüber J, Herrmann N, McDowell D, Ried A, Kampmann M Teiser B (2003) Ozonation: a tool for removal of pharmaceuticals, contrast media and musk fragrances from wastewater? Water Research 37(8), 1976–1982
Trautwein C, Kümmerer K (2011) Incomplete degradation of the antidiabetic Metformin and identification of the microbial dead-end transformation product Guanylurea. Chemosphere 85(5), 765–773
von Gunten U, Salhi E, Schmidt CK, Arnold WA (2010) Kinetics and Mechanisms of N-Nitrosodimethylamine Formation upon Ozonation of N,N-Dimethylsulfamide-Containing Waters: Bromide Catalysis. Environ. Sci. Technol. 44(15), 5762–5768
Weinberg HS, Krasner SW, Richardson SD, Thruston AD (2002) The occurrence of disinfection by-products (DBPs) of health concern in drinking water: results of a nationwide DBP occurrence study. EPA/600/R-02/068. http://www.epa.gov/athens/publications/reports/EPA_600_R02_068.pdf
Witt KL, Bishop JB, McFee AF, Kumaroo V. (1992) Induction of chromosomal damage in mammalian cells in vitro and in vivo by sulfapyridine or 5-aminosalicylic acid. Mutat Res. 283(1), 59–64.
Acknowledgments
We kindly acknowledge the fruitful discussions with Dr. Hermann H. Dieter (German Federal Environment Agency, Berlin), Dr. Klaus Schneider and Dr. Martin Hassauer (FoBiG GmbH, Freiburg, Germany) and the financial support of the investigations by the German Federal Environment Agency (UBA research grant no. 206 61 202)
Author information
Authors and Affiliations
Corresponding author
Additional information
Responsible editor: Hongwen Sun
Electronic supplementary materials
Below is the link to the electronic supplementary material.
ESM 1
(DOC 1.34 mb)
Rights and permissions
About this article
Cite this article
Gartiser, S., Hafner, C., Kronenberger-Schäfer, K. et al. Approach for detecting mutagenicity of biodegraded and ozonated pharmaceuticals, metabolites and transformation products from a drinking water perspective. Environ Sci Pollut Res 19, 3597–3609 (2012). https://doi.org/10.1007/s11356-012-0925-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11356-012-0925-x